Move With Air: Physiological Response Assessment

Sponsor
McGill University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05659550
Collaborator
(none)
21
1
3
17.7
1.2

Study Details

Study Description

Brief Summary

A fan blowing cool air to the face has been shown to alleviate breathlessness in malignant and non-malignant disease at rest and during exercise, however the underlying physiological mechanisms remain unknown. This random order, three-condition design study will explore physiological mechanisms of breathlessness relief with fan-to-face therapy during constant-rate exercise in people with cardiorespiratory disease.

Condition or Disease Intervention/Treatment Phase
  • Device: Honeywell HT-900 Turbo Force Air Circulator
N/A

Detailed Description

Constant work rate tests are viewed as the most suitable and sensitive method to assess exertional breathlessness. The 3-minute constant rate treadmill test (3-min CRTT) is a validated test wherein participants exercise at an intensity determined by an incremental test. For the purpose of this study, participants will perform three 3-min CRTT at 75% of peak power output, achieved during an incremental treadmill exercise test, under three experimental conditions: (i) fan to the face; (ii) fan to the leg; (iii) no fan. The order of the experimental conditions will be random for each participant. Cardiac and dynamic respiratory parameters will be collected breath-by-breath at rest and during exercise using the Hexokin Smart Shirt. In order to target the intranasal pathway located on the trigeminal nerve that is hypothesized to modulate the mechanisms governing the potential effectiveness of a fan to the face, a metabolic cart will be omitted due to the use of the facemask or mouthpiece and nasal clip that would block this pathway.

Using the Borg 0-10 scale, perceptions of breathlessness intensity, unpleasantness and leg fatigue will be assessed at rest, within the last 15-seconds of each minute of exercise, and at end exercise or the symptom limited peak of exercise. Two areas of facial skin temperature, one at the forehead to target the ophthalmic branch of the trigeminal nerve and the other at the cheek to target the maxillary branch of the trigeminal nerve, will be measured prior to exercise, within the last 15-seconds of each minute of exercise, at end exercise, and following exercise using a medical grade non-contact infrared forehead thermometer. The model number of the forehead thermometer that will be used is THERMOPROPCV2 and is licensed by Health Canada and approved by the U.S. Food and Drug Administration (FDA), CE approved with European health, safety, and environmental protection standards, and approved by the Restriction of Hazardous Substances Directive (RoHS).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
21 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Each participant will complete the same constant work rate exercise test under three different conditions.Each participant will complete the same constant work rate exercise test under three different conditions.
Masking:
None (Open Label)
Masking Description:
It is impossible to mask the participants or the investigator since they will be aware if the fan is pointed to the face, to the leg, or there is no fan. However, participants will not be informed of which interventional arm is suspected to be beneficial.
Primary Purpose:
Treatment
Official Title:
Move With Air: Can a Fan Reduce Exertional Breathlessness During a 3-minute Constant Rate Walking Test in Adults With Cardiopulmonary Disease?
Anticipated Study Start Date :
Jan 9, 2023
Anticipated Primary Completion Date :
Jun 9, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fan-to-face

The participants will complete a 3-minute constant work rate treadmill test at 75% of peak power output achieved on an incremental treadmill test with a basic, portable fan placed in front of the face. The fan will be placed at a location to target the second and third branches of the trigeminal nerve and will be placed a distance so that the maximum airflow speed at the face is 4.3 meters/second.

Device: Honeywell HT-900 Turbo Force Air Circulator
This is a basic, portable, household fan with a single cost of CDN$21.99.
Other Names:
  • Fan
  • Sham Comparator: Fan-to-leg

    The participants will complete a 3-minute constant work rate treadmill test at 75% of peak power output achieved on an incremental treadmill test with a basic, portable fan placed facing the side of the lower left leg (side calf area). The fan will be placed a distance so that the maximum airflow speed at the face is 4.3 meters/second.

    Device: Honeywell HT-900 Turbo Force Air Circulator
    This is a basic, portable, household fan with a single cost of CDN$21.99.
    Other Names:
  • Fan
  • No Intervention: No fan

    The participants will complete a 3-minute constant work rate treadmill test at 75% of peak power achieved on an incremental treadmill test with no fan.

    Outcome Measures

    Primary Outcome Measures

    1. Borg modified 0-10 category ratio scale for breathlessness intensity [End-exercise of the 3-minute constant rate treadmill test]

      Borg modified 0-10 category ratio scale will be used to assess breathlessness intensity at end-exercise of each 3-minute constant rate treadmill test under three conditions: (i) fan to the face; (ii) fan to the leg (sham) and; (iii) no fan (control). A higher score is indicative of greater breathlessness, while a lower score is indicative of lesser breathlessness.

    Secondary Outcome Measures

    1. Cardiopulmonary exercise test (3-minute constant rate) physiological response (ventilatory) [Averaged across the 3-minute constant rate treadmill test]

      Mean ventilation (Liters/minute) will be compared across the 3-minute constant rate treadmill tests under the three different conditions: (i) fan to the face; (ii) fan to the leg (sham) and; (iii) no fan (control). A greater mean ventilation is indicative of a less efficient respiratory system, whereas a lower mean ventilation is indicative of a more efficient respiratory system.

    2. Cardiopulmonary exercise test (3-minute constant rate) physiological response (operating lung volumes) [Averaged across the 3-minute constant rate treadmill test]

      Mean operating lung volumes (i.e., inspiratory capacity in liters) will be compared across the 3-minute constant rate treadmill tests under the three different conditions: (i) fan to the face; (ii) fan to the leg (sham) and; (iii) no fan (control). A greater operating lung volume (i.e., greater inspiratory capacity) is indicative of a better and more efficient breathing pattern, while a lower operating lung volume (i.e., smaller inspiratory capacity) is indicative of a worse and less efficient breathing pattern.

    3. Cardiopulmonary exercise test (3-minute constant rate) physiological response (heart rate) [Averaged across the 3-minute constant rate treadmill test]

      Mean heart rate (beats per minute) will be compared across the 3-minute constant rate treadmill tests under the three different conditions: (i) fan to the face; (ii) fan to the leg (sham) and; (iii) no fan (control). A lower heart rate is indicative of better cardiovascular fitness, while a higher heart rate is indicative of worse cardiovascular fitness.

    4. Cardiopulmonary exercise test (3-minute constant rate) physiological response (oxygen saturation) [Averaged across the 3-minute constant rate treadmill test]

      Mean oxygen saturation (in percentage) will be compared across the 3-minute constant rate treadmill tests under the three different conditions: (i) fan to the face; (ii) fan to the leg (sham) and; (iii) no fan (control). A lower oxygen saturation is indicative of worse health status, while a higher oxygen saturation is indicative of better health status.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • have a physician diagnosis of cardiopulmonary disease (e.g., chronic obstructive pulmonary disease, interstitial lung disease, heart failure)

    • must report breathlessness on exertion, defined as modified Medical Research Council dyspnea scale rating ≥2 despite optimal treatment of their underlying cardiopulmonary pathophysiology according to established clinical practice guidelines

    • have a body mass index of >18.5 kg/m2 and <35 kg/m2

    • must be cleared by a physician to perform physical activity/exercise following the completion of the 'Medical Clearance Form for Cardiopulmonary Exercise Testing'.

    Exclusion Criteria:
    • have changed their respiratory or cardiac medication dosage and/or frequency of administration in preceding two weeks

    • have had a disease exacerbation/hospitalization in preceding six weeks

    • have important contraindication(s) to exercise (e.g., significant musculoskeletal or neurological disease) or pulmonary function testing (e.g., eye, chest or stomach surgery, or any history of coughing up significant amounts of blood in the previous 3 months).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre of Innovative Medicine of the McGill University Health Centre Montreal Quebec Canada H4A 3J1

    Sponsors and Collaborators

    • McGill University

    Investigators

    • Principal Investigator: Dennis Jensen, PhD, McGill University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Dennis Jensen, Ph.D., Associate Professor, McGill University
    ClinicalTrials.gov Identifier:
    NCT05659550
    Other Study ID Numbers:
    • FanEx_2023-9286
    First Posted:
    Dec 21, 2022
    Last Update Posted:
    Dec 21, 2022
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dennis Jensen, Ph.D., Associate Professor, McGill University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 21, 2022